Efficiency of a jellyfish sting inhibitor sun lotion and protocols for jellyfish sting pain relief

• Conditions: The degree of pain reduction in test subjects using a specific jellyfish (cnidaria) sting inhibitor and repellent lotion, compared to control subjects being protected by a normal water repellent sunscreen or no sun lotion at all. The jellyfish exposed skin parts will be treated for pain relief with hot or cold therapy or a commercially available local pain relief product (xylocain) from pharmacy.

• Registration Number: EUCTR2008-001519-39-NO
• Lead Sponsor: Biologiske Stasjon Drøbak

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-03-31
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Healthy subjects over 18 years. The subjects can be of both sexes.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Subjects with a history of certain sorts of allergic reactions are being excluded to minimize any possible risk. Subjects with a history of unusual adverse reaction to insects, jellyfish, or other types of stings will be excluded.

•People with atopic diseases, e.g., asthma, allergic rhinorrhea or rhinitis, hay fever, or atopic skin inflammation
•Pregnancy.
•People who suffer from skin diseases in the testing regions or whose inner forearms are too hairy to allow for interpretation of the test
•People who have used any medical or cosmetic product on either arm for 48 hours before the start of the experiment
•People who are taking antihistamines or steroids
•Subjects with medical conditions which, in the opinion of the investigator, pose risks that would prohibit participating
•Subjects with a history of keloid formation will be excluded from the Jellyfish protocol
•Subjects with allergy to lidocain or other local pain substances

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified